Detalhe da pesquisa
1.
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models.
Br J Cancer
; 129(5): 884-894, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474721
2.
Novel small-molecule LG1836 inhibits the in vivo growth of castration-resistant prostate cancer.
Prostate
; 80(12): 993-1005, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32559345
3.
Proteomics-Metabolomics Combined Approach Identifies Peroxidasin as a Protector against Metabolic and Oxidative Stress in Prostate Cancer.
Int J Mol Sci
; 20(12)2019 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31234468
4.
Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models.
Transl Oncol
; 34: 101707, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37271121
5.
SNAIL Transctiption factor in prostate cancer cells promotes neurite outgrowth.
Biochimie
; 180: 1-9, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33132158
6.
Overcoming prostate cancer drug resistance with a novel organosilicon small molecule.
Neoplasia
; 23(12): 1261-1274, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781084
7.
Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer.
Theranostics
; 11(14): 6873-6890, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34093859